冠心病管理新理念与策略

What is new in the management of coronary artery disease in 2020

本文综合《2018 ESC/EACTS心肌血运重建指南》、《2019 ESC慢性冠状动脉综合征诊断与治疗指南》、《2019年ESC/EAS血脂异常管理指南》、《2019 ESC/EASD指南:糖尿病、糖尿病前期和心血管疾病》,以及COMPASS研究、2020 ACC COMPASS亚组研究、DEBUT研究、ISCHEMIA研究和BIOSTEMI研究等,总结2020年冠心病管理新理念,并在优化抗栓、强化降脂、新型降糖药物使用和积极血运重建等领域做出讨论。

This article synthesizes the"2018 ESC/EACTS Guidelines for Myocardial Revascularization",the"2019 ESC Guidelines for the Diagnosis and Treatment of Chronic Coronary Syndrome",the"2019 ESC/EAS Guidelines for the Management of Dyslipidemia",the"2019 ESC Guidelines on diabetes,pre-diabetes,and cardiovascular diseases",the COMPASS Study,and the 2020 ACC COMPASS Subgroup Study,DEBUT research,ISCHEMIA research,BIOSTEMI research.We summarize the new concepts of management of coronary heart disease in 2020,and discuss in the field of optimal antithrombotic therapy,strengthening lipid-lowering therapy,new types of glucose-lowering drugs,and active revascularization.